HIV pathogenesis: Mechanisms of susceptibility and disease progression

Current Opinion in Microbiology

Volumn 1, Issue 4, 1998, Pages 423-429

  Neil Simonsen, J ^a,b   Fowke, Keith R ^a   MacDonald, Kelly S ^b,c   Plummer, Francis A ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1;

COHORT ANALYSIS; DISEASE COURSE; DISEASE PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; REVIEW; SEXUALLY TRANSMITTED DISEASE;

COHORT STUDIES; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; HIV INFECTIONS; HIV-1; HUMANS; SEXUALLY TRANSMITTED DISEASES; VARIATION (GENETICS);

EID: 0032129769     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1369-5274(98)80060-x     Document Type: Article

References (70)

1. Newport MJ: Unraveling the genetic basis of susceptibility to infectious diseases. Curr Opin Infect Dis 1997, 10:233-238.
2. Royce RA, Sea A, Cates W Jr, Cohen MS: Sexual transmission of HIV. N Engl J Med 1997, 336:1072-1078.
3. Simonsen JN, Cameron DW, Gakinya MN, Ndinya-Achola JO, D'Costa LJ, Karasira P, Cheang M, Ronald AR, Piot P, Plummer FA: Human immunodeficiency virus infection among men with sexually transmitted diseases. N Engl J Med 1988, 319:274-278.
4. Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN, Chean M, Ndinya-Achola JO, Piot P, Brunham RC et al.: Female to male transmission of human immunodeficiency virus type 1 : risk factors for seroconversion in men. Lancet 1989, 2:403-407.
5. Simonsen JN, Plummer FA, Ngugi EN, Black C, Kreiss JK, Gakinya MN, Waiyaki P, D'Costa LJ, Ndinya-Achola JO, Piot P et al.: HIV infection among lower socioeconomic strata prostitutes in Nairobi. AIDS 1990, 4:139-144.
6. Pépin J, Plummer FA, Brunham RC, Piot P, Cameron DW, Ronald AR: Editorial review. The interaction of HIV infection and other sexually transmitted diseases: an opportunity for intervention. AIDS 1989, 3:3-6.
7. Wasserheit J: Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992, 19:61-77.
8. Plummer FA, Tyndall MW, Ndinya-Achola JO, Moses S: Sexual transmission of HIVs and the role of sexually transmitted diseases. In AIDS in Africa. Edited by Essex M, Mboup S, Kanki PJ, Kalengayi MR. New York: Raven Press; 1993:195-209.
9. Ngugi EN, Plummer FA, Simonsen JN, Cameron DW, Bosire M, Wayaki P, Ronald AR, Ndinya-Achola JO: Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes. Lancet 1988, 2:887-890.
10. Laga M, Alary M, Nzila N, Manoka AT, Tuliza M, Behets F, Goeman J, St Louis M, Piot P et al.: Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994, 344:246-248.
11. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, Mayaud P, Changalucha J, Nicoll A, Ka-Gina G et a/.: Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995, 346:530-536.
12. Pham-Kanter GB, Steinberg MH, Ballard RC: Sexually transmitted diseases in South Africa. Genitourin Med 1996, 72:160-171.
13. Meda N, Ledru S, Fofana M, Lankoande S, Soula G, Bazie AJ, Chiron JP: Sexually transmitted diseases and human immunodeficiency virus infection among women with genital infection in Burkina Faso. Int J STD AIDS 1995, 6:273-277.
14. Cohen CR, Duerr A, Pruithithada N, Rugpao S, Hillier S, Garcia P, Nelson K: Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995, 9:1093-1097.
15. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila M, Goeman J, Behets F, Batter V, Alary M et al.: Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993, 7:95-102.
16. Haynes BF, Pantaleo G, Fauci AS: Towards an understanding of the correlates of protective immunity to HIV infection. Science 1996, 271:324-328.
17. 7. Travers K, Mboup S, Marlink R, Gueye-Nidaye A, Siby T, Thior I, Traore I, Dieng-Sarr A, Sankali JL, Mullins C et al.: Natural protection against HIV-1 infection provided by HIV-2. Science 1995, 268:1612-1616.
18. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, MacDonald KS, Ngugi EN, Plummer FA: Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996, 348:1347-1351.
19. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA: Relative resistance to HIV-1 infection in CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat Med 1996, 3:412-417.
20. Lui R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell 1996, 86:367-377.
21. Quillent C, Oberlin E, Braun J, Rousset D, Gonzalez-Canali G, Mitais P, Montagnier L, Virelizier JL, Arenzana-Seisdedos F, Beretta A: HIV-1 resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 1998, 351:14-18. The first description of another allelic variant of CCR5 that is associated with the HIV-1 resistance phenotype.
22. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Winkler C, O'Brien SJ, Rinaldo C et al.: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996, 2:405-411.
23. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R et al.: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997, 277:959-65.
24. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, Deutsch L, Phair J, Neumann AU, Ho DD: A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998, 4:350-353.
25. Anzala AO, Ball TB, Rostron T, O'Brien SJ, Plummer FA, Rowland-Jones SL and the Unversity of Nairobi Collaborative for HIV Research: CCR2-64I allele and genotype association with delayed AIDS progression in African women. Lancet 1993, 351:1632-1634.
26. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honji T, Tashiro K, Yabe D et al.: Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene mutation. Science 1998, 279:389-393.
27. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
28. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR: Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987, 166:1229-1244.
29. Mosmann TR, Moore KW: The role of IL-10 in cross regulation of TH1 and TH2 responses. Immunol Today 1991, 12:A49-A53.
30. Fernandez-Botran R, Sanders VM, Mosmann TR, Vitetta ES: Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J Exp Med 1988, 168:543-558.
31. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H: Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 1992, 257:539-542.
32. Yang X, Hayglass KT, Brunham RC: Genetically determined differences in IL-10 and IFN? responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996, 156:4338-4344.
33. Gorham JD, Güler ML, Steen RG, Mackey AJ, Daly MJ, Frederick K, Dietrich WF, Murphy KM: Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Nat Acad Sci USA 1996, 93:12467-12472.
34. Clerici M, Clark EA, Polacino P, Axberg I, Kuller L, Casey NI, Morton WR, Shearer GM, Benveniste RE: T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macques. AIDS 1994, 8:1391-1395.
35. Modlin RL, Melancon-Kaplan J, Young SM, Pirmez C, Kino H, Convit J, Rea TH, Bloom BR: Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci USA 1988, 85:1213-1217.
36. Abel L, Demenais F, Prata A, Souza AF, Dessein A: Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 1991, 48:959-970.
37. Couissinier-Paris, P, Dessein, AJ: Schistosoma-specific T helper cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur J Immunol 1995, 25:2295-2302.
38. Bronowicki JP, Vetter D, Uhl G, Hudziak H, Uhrlacher A, Vetter JM, Doffoel M: Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J Infect Dis 1997 176:518-522. Second description of a viral infection in which exposure results in cytotoxic T lymphocyte responses in the absence of antibody production.
39. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA, Shearer GM: Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992, 165:1012-1019.
40. Pinto LA, Sullivan J, Berzofsky JA, Clerici M, Kessler HA, Landay AL, Shearer GM: ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 1995, 96:867-876.
41. Rowland-Jones SL, Nixon DF, Aldhous MC, Gotch F, Ariyoshi K, Hallam N, Kroll JS, Froebel K, McMichael A: HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993, 341:860-861.
42. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E: Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in non-infected heterosexual contact of HIV-infected patients. J Clin Invest 1994, 93:1293-1297.
43. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T et al.: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995, 1:59-64.
44. + T cells. Immunol Today 1996, 17:217-224.
45. Salk J, Bretscher PA, Salk PL, Clerici M, Shearer GM: A strategy for prophylactic vaccination against HIV. Science 1993, 260:1270-1272.
46. + peripheral T lymphocytes and natural killer cells in the antibody-dependent cellular cytotoxicity (ADCC) system. J Immunol 1997, 158:5492-5500.
47. Wallance M, Bartz SR, Change WL, Mackenzie DA, Pauza CD, Malkovsky M: T lymphocyte responses to HIV. Clin Exp Immunol 1996, 103:177-184.
48. Greenough TC, Brettler DB, Somasundaran M, Panicali DL, Sullivan JL: Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. J Infect Dis 1997, 176:118-225. Solid data supporting the hypothesis that effective cytotoxic T lymphocytes responses correlate with delayed disease progression.
49. Cao Y, Qin L, Zhang L, Safrit J, Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995, 332:201-208.
50. Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, Giangrande P, Luzzi G, Morgan B, Edwards A et al.: Late escape from an immunodominant cytotoxic T lymphocyte response associated with progression to AIDS. Nat Med 1997, 2:205-211.
51. Zhang C, Cui Y, Houston S, Chang L-J: Protective immunity to HIV-1 in SCID/beige mice reconstituted with the peripheral blood lymphocytes of exposed but uninfected individuals. Proc Nat Acad Sci USA 1996, 93:14720-14725.
52. + T cells. Science 1995, 270:1811-1815.
53. Mackewicz CE, Levy JA, Cruikshank WW, Kornfeld H, Center DM: Role of IL-16 in HIV replication. Nature 1996, 383:488-489.
54. Broder CC, Dimitrov DS: HIV and the 7-transmembrane domain receptors. Pathobiology 1996, 64:171-179.
55. + T-cell-mediated suppression of HIV-1 infection may not be due to chemokines RANTES, MIP-1α, and MIP-1β. AIDS 1996, 10:1434-1435.
56. + T-cell-mediated suppression of HIV long terminal repeat-driven gene expression is not associated with improved clinical status, AIDS 1997, 11:581-586.
57. Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Bli C, Meacci F, Ruzzante S, Salvi A, Semplici F, Longhi R et al.: HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seronegative individuals. Nat Med 1997, 3:1-8.
58. Luwy M, Hu Y, Eckert L, Christensen M, Karchmer T, McElrath MJ: HIV-1 induces cytoxic T lymphocytes in the cervix of infected women. J Exp Med 1997, 185:293-303.
59. Rutherford GW, Lifson AR, Hessol NA, Darrow WW, O'Malley PM, Buchbinder SP, Barnhart JL, Bodecker TW, Cannon L, Doll LS et al.: Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow up study. Br Med J 1990, 301:1183-1188.
60. Lee CA, Phillips AN, Elford J, Janossy G, Griffiths P, Kernoff P: Progression of HIV disease in a haemophiliac cohort followed for 11 years and the effect of treatment Br Med J 1991, 303:1093-1096.
61. Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner HU, Mulder DW, Whitworth JA: HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997, 350:245-250.
62. Nagelkerke NJ, Plummer FA, Holton D, Anzala AO, Manji F, Ngugi EN, Moses S: Transition dynamics of HIV disease in a cohort of African prostitutes: a Markov model approach. AIDS 1990, 4:743-747.
63. Anzala OA, Nagelkerke NJ, Bwayo JJ, Holton D, Moses S, Ngugi EN, Ndinya-Achola JO, Plummer FA: Rapid progression to disease in African sex workers with human immunodeficiency type 1 infection. J Infect Dis 1995, 171:686-689.
64. Manaloto CR, Perrault JG, Caringal LT, Santiago EG, Wignall FS, Gonzales VL, Anthony RL, Hayes CG: Natural history of HIV infection in Filipino female commercial sex workers. J Acquir Immune Defic Syndr 1994, 7:1157-1168.
65. Levy JA: HIV pathogenesis and long-term survival. AIDS 1993, 7:1401-1418.
66. McKenzie S: Serum chemokine levels in patients with non-progressing HIV infection. AIDS 1996, 10:29-33.
67. Clerici M, Balotta C, Trabatloni D, Papagno L, Ruzzante S, Rusconi S, Fusi ML, Colombo MC, Galli M: Chemokine production in HIV-seropositive long-term asymptomatic individuals. AIDS 1996, 10:1432-1433.
68. Pantaleo G, Graziosi C, Fauci AS: The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1994, 328:327-335.
69. + T cell responses associated with control of viremia. Science 1997, 278:1447-1450. Excellent data supporting a link between potent HIV-1 specific cytotoxic T lymphocyte responses and control of viremia.
70. Blanchard A, Montagnier L, Gougeon M-L: Influence of microbial infections on the progression of HIV disease. Trends Microbiol 1997, 5:326-331. A detailed review on the interaction between other infections and HIV in mediating disease progression.